J
Juno Therapeutics
Is a clinical-stage company, develops immunotherapies for the treatment of cancer
At a glance
- Status
- Listed
- Listing
- IPO 2014
News
Knowledge graph
Market map
Rare Disease Therapeutics & Technologies Landscape
Market map
1k+ Global Genetics & Genomics startups
Unicorn list
Biotech & Life Sciences unicorns
Unicorn list
Unicorns in United States
Open roles
Juno Therapeutics in the Seattle ecosystem
The Juno Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Bezos Expeditions
Venrock- AFAlaska Permanent Fund
ARCH Venture Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former Juno Therapeutics employees who went on to found companies, sorted by Dealroom signal score.
XTXaira TherapeuticsEst. 2023
Marc Tessier-LavigneUnited States
UBUmoja BiopharmaEst. 2019
Maddie WilliamsUnited States
OPOnQuality PharmaceuticalsEst. 2018
HONG TANG, MD, FACPChinaPatents
174 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Juno Therapeutics was the backer or acquirer, 2015–2020. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
6 deals across Juno Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Juno Therapeutics deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Juno Therapeutics's portfolio, mapped.
See Juno Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.